Literature DB >> 15868171

A contribution to the controversy over dimethyl sulfoxide toxicity: anesthesia monitoring results in patients treated with Onyx embolization for intracranial aneurysms.

A G Pamuk1, I Saatci, H S Cekirge, U Aypar.   

Abstract

Onyx injection is a new technique for embolization of cerebral aneurysms that is involved in a controversy about the 'toxicity' of its solvent, dimethyl sulfoxide (DMSO). We retrospectively studied 38 patients treated for aneurysms with the liquid polymer, Onyx. Induction was with propofol, fentanyl and vecuronium, and anesthesia was maintained with isoflurane in O2 and N2O. The patients were given 500 ml of fluid after induction, and bradycardia was prevented in order to keep patients hyperdynamic. Electrocardiography (ECG), non-invasive blood pressure (NIBP), pulse oximetry, core temperatures, invasive blood pressure (BP), etCO2, and urine output were monitored throughout the intervention. Heart rate and BP changes in response to balloon inflation, DMSO injection, Onyx injection and balloon deflation were recorded. The patients were followed with serial neurological examinations, computerized tomography and/or magnetic resonance imaging postoperatively for evidence of any neurological injury. Cumulative DMSO doses were always well under previously implicated doses for systemic toxicity. No changes implicating toxic reactions were observed during DMSO and Onyx injections. Balloon-induced changes returned to baseline within 1 min of balloon deflation. Technique-related permanent morbidity occurred in two patients (worsening of cranial nerve palsies in one and monocular blindness in another) and intracranial hemorrhage with resulting death in one patient. All patients showed a tendency to oxygen desaturation, but this finding did not cause any clinical consequence. Anesthesiologists need to be vigilant in monitoring patients treated with techniques that are new or are being developed. We have seen no evidence of toxicity or any anesthetic complications in our group of patients, our only clinical concern being a tendency to oxygen desaturation, which may be explained by the inhalational elimination of DMSO.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868171     DOI: 10.1007/s00234-004-1323-y

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  25 in total

1.  Dimethyl sulfoxide affects the selection of splice sites.

Authors:  L Bolduc; B Labrecque; M Cordeau; M Blanchette; B Chabot
Journal:  J Biol Chem       Date:  2001-03-01       Impact factor: 5.157

2.  Embolization of cerebral arteriovenous malformations: Part I--Technique, morphology, and complications.

Authors:  G Wikholm; C Lundqvist; P Svendsen
Journal:  Neurosurgery       Date:  1996-09       Impact factor: 4.654

3.  Dimethyl sulfoxide in musculoskeletal disorders.

Authors:  C H Demos; G L Beckloff; M N Donin; P M Oliver
Journal:  Ann N Y Acad Sci       Date:  1967-03-15       Impact factor: 5.691

4.  A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model.

Authors:  J C Chaloupka; D C Huddle; J Alderman; S Fink; R Hammond; H V Vinters
Journal:  AJNR Am J Neuroradiol       Date:  1999-03       Impact factor: 3.825

5.  Structural basis for biological activities of dimethyl sulfoxide.

Authors:  N Kharasch; B S Thyagarajan
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

6.  Modification of cyanoacrylate for therapeutic embolization: preliminary experience.

Authors:  L D Cromwell; C W Kerber
Journal:  AJR Am J Roentgenol       Date:  1979-05       Impact factor: 3.959

7.  Dimethyl sulfoxide for the treatment of intracranial hypertension: a preliminary trial.

Authors:  L F Marshall; P E Camp; S A Bowers
Journal:  Neurosurgery       Date:  1984-06       Impact factor: 4.654

8.  Morphologic effect of dimethyl sulfoxide on the blood-brain barrier.

Authors:  R D Broadwell; M Salcman; R S Kaplan
Journal:  Science       Date:  1982-07-09       Impact factor: 47.728

9.  Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile.

Authors:  Y Murayama; F Viñuela; A Ulhoa; Y Akiba; G R Duckwiler; Y P Gobin; H V Vinters; R J Greff
Journal:  Neurosurgery       Date:  1998-11       Impact factor: 4.654

10.  Technical feasibility and histopathologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model.

Authors:  J C Chaloupka; F Viñuela; H V Vinters; J Robert
Journal:  AJNR Am J Neuroradiol       Date:  1994-06       Impact factor: 3.825

View more
  14 in total

1.  Late angiographic and clinical follow-up results of 100 consecutive aneurysms treated with Onyx reconstruction: largest single-center experience.

Authors:  H Saruhan Cekirge; Isil Saatci; M Halil Ozturk; Barbaros Cil; Anil Arat; Michel Mawad; Fikret Ergungor; Deniz Belen; Uygur Er; Sami Turk; Murat Bavbek; Zeki Sekerci; Ethem Beskonakli; Osman E Ozcan; Tuncalp Ozgen
Journal:  Neuroradiology       Date:  2006-01-04       Impact factor: 2.804

2.  A contribution to the controversy over dimethyl sulfoxide toxicity: anesthesia monitoring results in patients treated with Onyx embolization for intracranial aneurysms.

Authors:  Helmut Preiss
Journal:  Neuroradiology       Date:  2006-02-28       Impact factor: 2.804

3.  Facial and lower cranial neuropathies after preoperative embolization of jugular foramen lesions with ethylene vinyl alcohol.

Authors:  Brian C Gartrell; Marlan R Hansen; Bruce J Gantz; Michael B Gluth; Sarah E Mowry; Beverly L Aagaard-Kienitz; Mustafa K Baskaya; Samuel P Gubbels
Journal:  Otol Neurotol       Date:  2012-09       Impact factor: 2.311

Review 4.  Design and biocompatibility of endovascular aneurysm filling devices.

Authors:  Jennifer N Rodriguez; Wonjun Hwang; John Horn; Todd L Landsman; Anthony Boyle; Mark A Wierzbicki; Sayyeda M Hasan; Douglas Follmer; Jesse Bryant; Ward Small; Duncan J Maitland
Journal:  J Biomed Mater Res A       Date:  2014-08-04       Impact factor: 4.396

5.  In-situ injectable physically and chemically gelling NIPAAm-based copolymer system for embolization.

Authors:  Bae Hoon Lee; Bianca West; Ryan McLemore; Christine Pauken; Brent L Vernon
Journal:  Biomacromolecules       Date:  2006-06       Impact factor: 6.988

6.  Asystole during Onyx embolization of 64-year-old patient with dural arteriovenous fistula.

Authors:  Muhammad H Malik; Waleed Brinjikji; Luis E Savastano
Journal:  Neuroradiol J       Date:  2021-09-22

7.  Incidental occlusion of anterior spinal artery due to Onyx reflux in embolization of spinal type II arteriovenous malformation.

Authors:  Joohyun Kim; Jang-Bo Lee; Tai-Hyoung Cho; Junseok W Hur
Journal:  Eur Spine J       Date:  2016-09-26       Impact factor: 3.134

8.  Trigeminocardiac reflex in embolization of intracranial dural arteriovenous fistula.

Authors:  X Lv; Y Li; M Lv; A Liu; J Zhang; Z Wu
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

9.  Severe pulmonary oedema following therapeutic embolization with Onyx for cerebral arteriovenous malformation.

Authors:  C Murugesan; Sundararaj Saravanan; John Rajkumar; Jagadish Prasad; Sanjay Banakal; Kanchi Muralidhar
Journal:  Neuroradiology       Date:  2008-05       Impact factor: 2.804

10.  Acute respiratory distress syndrome after onyx embolization of arteriovenous malformation.

Authors:  Isaac Tawil; Andrew P Carlson; Christopher L Taylor
Journal:  Crit Care Res Pract       Date:  2011-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.